1-2 of 2
Inge de Greef, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide with or without Erythropoietin and Granulocyte-Colony Stimulating Factor Shows Efficacy in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndrome with or without Del 5q, Refractory or Unlikely to Respond to Erythropoietin. Results of a HOVON89 Phase II Randomized Multicenter Study. (EudraCT 2008-002195-10)

Arjan A. van de Loosdrecht, MD PhD, Dana A Chitu, PhD, Eline MP Cremers, MD, Theresia M Westers, PhD, Canan Alhan, MD, Heleen Visser-Wisselaar, PhD, Annelies Verbrugge, Petra Muus, MD PhD, Inge de Greef, MD PhD, Pierre W Wijermans, MD, Joop H. Jansen, PhD, Saskia K. Klein, MD PhD, Edo Vellenga, MD PhD, Marie-Cecile Legdeur, MD PhD, Wendy Deenik, MD PhD, Mojca jongen-Lavrencic, MD PhD, Rien van Marwijk-Kooy, Bea Tanis, MD PhD, Jurgen Wegman, Tanja van Maanen, Gert Ossenkoppele, MD PhD
Journal: Blood
Blood (2016) 128 (22): 224.
https://doi.org/10.1182/blood.V128.22.224.224
Published: 2016
Journal Articles

High Prognostic Impact of Mixed Chimerism of Blood and Marrow In the First Year After Allogeneic Hematopoietic Stem Cell Transplantation: The Need to Rapidly Establish Complete Donor Chimerism.

Ellen Meijer, MD, PhD, Lucia Duinhouwer, Eric Braakman, PhD, Joke Boonstra, PhD, Inge de Greef, MD, PhD, Jeanette Doorduijn, MD, PhD, Mojca Lavrencic, MD, PhD, Bob Lowenberg, MD, PhD, Jan Cornelissen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3464.
https://doi.org/10.1182/blood.V116.21.3464.3464
Published: 2010